Noureddine Idris-Khodja1, Sofiane Ouerd, Michelle Trindade, Jordan Gornitsky, Asia Rehman, Tlili Barhoumi, Stefan Offermanns, Frank J Gonzalez, Mario F Neves, Pierre Paradis, Ernesto L Schiffrin. 1. aHypertension and Vascular Research Unit, Lady Davis Institute for Medical Research bDepartment of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Quebec, Canada cDepartment of Clinical Medicine, State University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil dDepartment of Pharmacology, Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany eLaboratory of Metabolism, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA *Noureddine Idris-Khodja and Sofiane Ouerd contributed equally to the article.
Abstract
AIMS: Peroxisome proliferator-activated receptor γ (PPARγ) agonists reduce blood pressure and vascular injury in hypertensive rodents. Pparγ inactivation in vascular smooth muscle cells (VSMC) enhances vascular injury. Transgenic mice overexpressing endothelin (ET)-1 selectively in the endothelium (eET-1) exhibit endothelial dysfunction, increased oxidative stress and inflammation. We hypothesized that inactivation of the Pparγ gene in VSMC (smPparγ-/-) would exaggerate ET-1-induced vascular injury. METHODS AND RESULTS: eET-1, smPparγ-/- and eET-1/smPparγ-/- mice were treated with tamoxifen for 5 days and studied 4 weeks later. SBP was higher in eET-1 and unaffected by smPparγ inactivation. Mesenteric artery vasodilatory responses to acetylcholine were impaired only in smPparγ-/-. N(omega)-Nitro-L-arginine methyl ester abrogated relaxation responses, and the Ednra/Ednrb mRNA ratio was decreased in eET-1/smPparγ-/-, which could indicate that nitric oxide production was enhanced by ET-1 stimulation of endothelin type B receptors. Mesenteric artery media/lumen was greater only in eET-1/smPparγ-/-. Mesenteric artery reactive oxygen species increased in smPparγ and were further enhanced in eET-1/smPparγ-/-. Perivascular fat monocyte/macrophage infiltration was higher in eET-1 and smPparγ and increased further in eET-1/smPparγ-/-. Spleen CD11b+ cells were increased in smPparγ-/- and further enhanced in eET-1/smPparγ-/-, whereas Ly-6C(hi) monocytes increased in eET-1 and smPparγ-/- but not in eET-1/smPparγ-/-. Spleen T regulatory lymphocytes increased in smPparγ and decreased in eET-1, and decreased further in eET-1/smPparγ-/-. CONCLUSION: VSMC Pparγ inactivation exaggerates ET-1-induced vascular injury, supporting a protective role for PPARγ in hypertension through modulation of pro-oxidant and proinflammatory pathways. Paradoxically, ET-1 overexpression preserved endothelial function in smPparγ-/- mice, presumably by enhancing nitric oxide through stimulation of endothelin type B receptors.
AIMS: Peroxisome proliferator-activated receptor γ (PPARγ) agonists reduce blood pressure and vascular injury in hypertensive rodents. Pparγ inactivation in vascular smooth muscle cells (VSMC) enhances vascular injury. Transgenic mice overexpressing endothelin (ET)-1 selectively in the endothelium (eET-1) exhibit endothelial dysfunction, increased oxidative stress and inflammation. We hypothesized that inactivation of the Pparγ gene in VSMC (smPparγ-/-) would exaggerate ET-1-induced vascular injury. METHODS AND RESULTS: eET-1, smPparγ-/- and eET-1/smPparγ-/- mice were treated with tamoxifen for 5 days and studied 4 weeks later. SBP was higher in eET-1 and unaffected by smPparγ inactivation. Mesenteric artery vasodilatory responses to acetylcholine were impaired only in smPparγ-/-. N(omega)-Nitro-L-arginine methyl ester abrogated relaxation responses, and the Ednra/Ednrb mRNA ratio was decreased in eET-1/smPparγ-/-, which could indicate that nitric oxide production was enhanced by ET-1 stimulation of endothelin type B receptors. Mesenteric artery media/lumen was greater only in eET-1/smPparγ-/-. Mesenteric artery reactive oxygen species increased in smPparγ and were further enhanced in eET-1/smPparγ-/-. Perivascular fat monocyte/macrophage infiltration was higher in eET-1 and smPparγ and increased further in eET-1/smPparγ-/-. Spleen CD11b+ cells were increased in smPparγ-/- and further enhanced in eET-1/smPparγ-/-, whereas Ly-6C(hi) monocytes increased in eET-1 and smPparγ-/- but not in eET-1/smPparγ-/-. Spleen T regulatory lymphocytes increased in smPparγ and decreased in eET-1, and decreased further in eET-1/smPparγ-/-. CONCLUSION:VSMC Pparγ inactivation exaggerates ET-1-induced vascular injury, supporting a protective role for PPARγ in hypertension through modulation of pro-oxidant and proinflammatory pathways. Paradoxically, ET-1 overexpression preserved endothelial function in smPparγ-/- mice, presumably by enhancing nitric oxide through stimulation of endothelin type B receptors.
Authors: I Barroso; M Gurnell; V E Crowley; M Agostini; J W Schwabe; M A Soos; G L Maslen; T D Williams; H Lewis; A J Schafer; V K Chatterjee; S O'Rahilly Journal: Nature Date: 1999 Dec 23-30 Impact factor: 49.962
Authors: P Delerive; F Martin-Nizard; G Chinetti; F Trottein; J C Fruchart; J Najib; P Duriez; B Staels Journal: Circ Res Date: 1999-09-03 Impact factor: 17.367
Authors: Quy N Diep; Mohammed El Mabrouk; Jeffrey S Cohn; Dierk Endemann; Farhad Amiri; Agostino Virdis; Mario Fritsch Neves; Ernesto L Schiffrin Journal: Circulation Date: 2002-05-14 Impact factor: 29.690
Authors: Anne Aries; Pierre Paradis; Chantal Lefebvre; Robert J Schwartz; Mona Nemer Journal: Proc Natl Acad Sci U S A Date: 2004-04-20 Impact factor: 11.205
Authors: David S Calnek; Louis Mazzella; Susanne Roser; Jesse Roman; C Michael Hart Journal: Arterioscler Thromb Vasc Biol Date: 2003-01-01 Impact factor: 8.311
Authors: Joseph Schragenheim; Lars Bellner; Jian Cao; Shailendra P Singh; David Bamshad; John A McClung; Omri Maayan; Aliza Meissner; Ilana Grant; Charles T Stier; Nader G Abraham Journal: Prostaglandins Other Lipid Mediat Date: 2018-05-19 Impact factor: 3.072
Authors: Thomas J Jurrissen; Zachary I Grunewald; Makenzie L Woodford; Nathan C Winn; James R Ball; Thomas N Smith; Andrew A Wheeler; Arthur L Rawlings; Kevin F Staveley-O'Carroll; Yan Ji; William P Fay; Pierre Paradis; Ernesto L Schiffrin; Victoria J Vieira-Potter; Paul J Fadel; Luis A Martinez-Lemus; Jaume Padilla Journal: Am J Physiol Endocrinol Metab Date: 2019-07-16 Impact factor: 4.310
Authors: Józefa Dąbek; Joanna Piotrkowicz; Joanna Głogowska-Ligus; Małgorzata Domagalska-Szopa; Andrzej Szopa; Lutz Schreiber Journal: Int J Environ Res Public Health Date: 2022-06-14 Impact factor: 4.614
Authors: Roberto Palacios-Ramírez; Raquel Hernanz; Angela Martín; José V Pérez-Girón; María T Barrús; Zoe González-Carnicero; Andrea Aguado; Frederic Jaisser; Ana M Briones; Mercedes Salaices; María J Alonso Journal: Sci Rep Date: 2019-11-11 Impact factor: 4.379